Home » Newsletters » BioWorld

BioWorld

April 15, 1996

View Archived Issues

ARONEX PHARMACEUTICALS REGISTERS TO SELL 6M SHARES

RIBOZYME'S INITIAL PUBLIC OFFERING PRICED AT $10 PER SHARE

LAWSUIT CLAIMING MEDICAL PROCEDURE PATENT RULED INVALID

OTHER NEWS TO NOTE

CANADIANS FIND EIGHTH JUVENILE-DIABETES GENE MAPPED SINCE 1973; NONE

SIGNAL SIGNS $46M DEAL WITH JAPANESE DRUG MAKER